MDT

87.11

-0.93%↓

115.09

-0.3%↓

VEEV

151.46

-3.57%↓

HQY

78.12

-6.83%↓

TLRY

6.58

-1.94%↓

MDT

87.11

-0.93%↓

115.09

-0.3%↓

VEEV

151.46

-3.57%↓

HQY

78.12

-6.83%↓

TLRY

6.58

-1.94%↓

MDT

87.11

-0.93%↓

115.09

-0.3%↓

VEEV

151.46

-3.57%↓

HQY

78.12

-6.83%↓

TLRY

6.58

-1.94%↓

MDT

87.11

-0.93%↓

115.09

-0.3%↓

VEEV

151.46

-3.57%↓

HQY

78.12

-6.83%↓

TLRY

6.58

-1.94%↓

MDT

87.11

-0.93%↓

115.09

-0.3%↓

VEEV

151.46

-3.57%↓

HQY

78.12

-6.83%↓

TLRY

6.58

-1.94%↓

Home・Akciju saraksts・Treace Medical Concepts Inc

Treace Medical Concepts Inc

Slēgts

1.8 17.65

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

1.5

Max

2.13

Galvenie mērījumi
By Trading Economics
Ienākumi	6.9M -9.4M
Pārdošana	12M 63M
Peļņas marža	-15.026
Darbinieki	450
EBITDA	7M -5.2M

Rekomendācijas
By TipRanks
Rekomendācijas	Neitrāls
Prognoze 12 mēnešiem	+132.68% upside

Dividendes
By Dow Jones
Nākamie ieņēmumi	2026. g. 7. maijs

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	-35M 93M
Iepriekšējā atvēršanas cena	-15.85
Iepriekšējā slēgšanas cena	1.8

Tehniskais rādītājs

By Trading Central

Pārliecība

Strong Bullish Evidence

7.16 / 7.65 Atbalsts un pretestība

Treace Medical Concepts Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 10. apr. 17:04 UTC

Galvenie tirgus virzītāji

FDA Rejects Replimune's Melanoma Drug for a Second Time

2026. g. 11. apr. 00:00 UTC

Peļņas

Iegādes, apvienošanās, pārņemšana

Big Yachts, Big Bucks -- Barrons.com

2026. g. 10. apr. 21:55 UTC

Iegādes, apvienošanās, pārņemšana

Paramount Warrants Are an Underappreciated Aspect of Warner Bros. Deal -- Barrons.com

2026. g. 10. apr. 21:01 UTC

Peļņas

Cango Inc.: Files Annual Report on Form 20-F With SEC

2026. g. 10. apr. 20:50 UTC

Tirgus saruna

Energy & Utilities Roundup: Market Talk

2026. g. 10. apr. 20:50 UTC

Tirgus saruna

Galvenie ziņu notikumi

Basic Materials Roundup: Market Talk

2026. g. 10. apr. 20:50 UTC

Tirgus saruna

Health Care Roundup: Market Talk

2026. g. 10. apr. 20:31 UTC

Tirgus saruna

Convenience Store Traffic Slows as Gas Prices Rise -- Market Talk

2026. g. 10. apr. 20:10 UTC

Iegādes, apvienošanās, pārņemšana

This Women's Health Company Is Drawing Takeover Interest. The Stock Is Soaring. -- Barrons.com

2026. g. 10. apr. 19:15 UTC

Tirgus saruna

Global Energy Roundup: Market Talk

2026. g. 10. apr. 19:15 UTC

Tirgus saruna

Oil Futures Settle Lower With Focus on U.S.-Iran Talks -- Market Talk

2026. g. 10. apr. 19:08 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2026. g. 10. apr. 19:08 UTC

Tirgus saruna

U.S. Natural Gas Futures End Week Lower -- Market Talk

2026. g. 10. apr. 18:38 UTC

Tirgus saruna

Canada's Job Market Showing Soft Demand, Structural Decline in Supply -- Market Talk

2026. g. 10. apr. 18:25 UTC

Tirgus saruna

Galvenie ziņu notikumi

Precious Metals Finish With Weekly Gains -- Market Talk

2026. g. 10. apr. 18:05 UTC

Tirgus saruna

Rising Commodity Prices Seen Carrying More Weight Than Jobs Data for Bank of Canada Watchers -- Market Talk

2026. g. 10. apr. 17:31 UTC

Tirgus saruna

Galvenie ziņu notikumi

U.S. Oil Rig Count Unchanged This Week At 411 -- Market Talk

2026. g. 10. apr. 17:26 UTC

Peļņas

Big Banks' Profits Set to Rise Even as 'Wall of Worry' Looms -- Barrons.com

2026. g. 10. apr. 17:10 UTC

Tirgus saruna

White House Defense of Stablecoin Yields Is Welcome Move, Grayscale Says -- Market Talk

2026. g. 10. apr. 17:00 UTC

Galvenie ziņu notikumi

Construction Business Taking a Hit From Iran Conflict -- WSJ

2026. g. 10. apr. 16:20 UTC

Tirgus saruna

Health Care Roundup: Market Talk

2026. g. 10. apr. 16:15 UTC

Tirgus saruna

Global Commodities Roundup: Market Talk

2026. g. 10. apr. 16:12 UTC

Peļņas

Partners Group CEO: Group Well Positioned to Navigate Current Complex Environment

2026. g. 10. apr. 16:11 UTC

Peļņas

Partners Group: Traditional Programs Contributed $3.3B

2026. g. 10. apr. 16:10 UTC

Peļņas

Partners Group: $5B of New Commitments Came From Bespoke Solutions

2026. g. 10. apr. 16:10 UTC

Peļņas

Partners Group: That Is Across All Private Markets Asset Classes and Client Strategies

2026. g. 10. apr. 16:10 UTC

Peļņas

Partners Group 1Q New Client Demand $8.3B

2026. g. 10. apr. 16:09 UTC

Peļņas

Partners Group Continued to See Positive Fundraising Momentum in 1Q

2026. g. 10. apr. 15:54 UTC

Iegādes, apvienošanās, pārņemšana

Plenitude Completes Acquisition of Acea Energia

2026. g. 10. apr. 15:38 UTC

Tirgus saruna

Global Energy Roundup: Market Talk

Salīdzinājums

Cenas izmaiņa

Treace Medical Concepts Inc Prognoze

Cenas mērķis

By TipRanks

132.68% augšup

Prognoze 12 mēnešiem

Vidējais 3.56 USD 132.68%

Augstākais 7 USD

Zemākais 2 USD

Pamatojoties uz 4 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Treace Medical Concepts Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Neitrāls

4 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 4 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam Treace Medical Concepts Inc — pēdējo 3 mēnešu laikā.

Tehniskais rādītājs

By Trading Central

7.16 / 7.65Atbalsts un pretestība

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

There is one bullish event.

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par Treace Medical Concepts Inc

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.